HoldsUp

FoundMyFitness · 2024-06-12 · Andrew Huberman, Rhonda Patrick (host)

Andrew Huberman, PhD: How to Improve Motivation & Focus By Leveraging Dopamine

77 claims checked against research: 1 contradicted 12 overstated 6 needing context 51 supported 7 unverified

6

Needs context

0:05:08Andrew Hubermanneeds contexthigh

Dopamine neurons in the substantia nigra are critical for generating smooth movement and degenerate in Parkinson's disease, causing elevated resting tremor and difficulty initiating movement.

"Most notably in a brain area called the ventral tegmentum, which just means the floor of the midbrain, which is called the substantia nigra because the neurons there are dark. And those neurons are critically important for generating smooth movements. Those are the neurons that degenerate in Parkinson's, and that's why you see an elevated resting tremor and difficulty initiating movement in people with Parkinson's." (said at 0:05:08)

The speaker correctly identifies that dark (melanin-containing) dopaminergic neurons degenerate in Parkinson's disease, leading to classic cardinal motor features such as resting tremor and difficulty initiating movement (bradykinesia/akinesia). However, the speaker conflates the substantia nigra with the ventral tegmental area (VTA), equating the two ("in a brain area called the ventral tegmentum... which is called the substantia nigra"). Anatomically, the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA) are adjacent but distinct midbrain dopaminergic regions. SNc dopaminergic neurons preferentially degenerate in Parkinson's disease compared to VTA neurons, making the identification of the substantia nigra as the ventral tegmentum anatomical imprecision that requires qualification.

0:26:13Andrew Hubermanneeds contexthigh

In reward prediction error signaling, dopamine is released during the anticipation/pursuit of a reward; if the received reward exceeds expectations, dopamine fires further, but if it is worse than expected, dopamine drops below baseline.

"And then we shouldn't forget about the anticipation aspect of it itself, which is what's called reward prediction error. There's a classic experiment where essentially it was discovered that dopamine is being released en route to a reward while a monkey or human is working for a reward. And that itself was a cool discovery. It was like, "Wow, dopamine isn't just, you know, when the monkey gets the juice or when the person gets the monetary reward. It's when they think they're on the right path or they might get a reward. That's when dopamine's released." Then they get the reward. If the reward is equal to or in excess of what they anticipated, boom, they get a bit more dopamine. What better way to reinforce a behavior at the neural level? But if the reward is less exciting, or less money, or less intense than what one anticipates, what happens? Dopamine levels drop. And then they drop below baseline when they are on their way to eventually returning to baseline" (said at 0:26:13)

Electrophysiological studies in non-human primates and neuroimaging studies in humans establish that midbrain dopamine neurons encode reward prediction errors (RPE). During learning, phasic dopamine firing shifts from the unconditioned reward to the reward-predicting cue. When a reward is delivered, dopamine neurons increase their firing above baseline if the outcome is greater than expected (positive prediction error) and depress firing below baseline if the outcome is omitted or worse than expected (negative prediction error). However, when an outcome exactly matches expectations (fully predicted reward, RPE = 0), dopamine neurons remain at baseline activity rather than firing further.

0:57:50Andrew Hubermanneeds contextlow

The cessation or removal of a painful or difficult stimulus causes a neurochemical increase in catecholamines including dopamine, epinephrine, and norepinephrine.

"the ending of the difficult thing creates a an an increase—we know this—the removal of pain creates an increase in the catecholamines that—it's like the we, you know, one—I'm interrupting myself, but from an evolutionary standpoint, if we go back to like what this circuitry really evolved for, it's like you just survived the effort. You just you you just survived something, which is a tremendous relief, which is a it's a lift. And but when I say it's a lift, as a biologist, I have to acknowledge it's it's a neurochemical lift: dopamine, epinephrine, norepinephrine no doubt involved." (said at 0:57:50)

Relief from pain or the termination of an aversive stimulus is well-documented in preclinical models and human neuroimaging to act as a reward (negative reinforcement) that triggers dopamine release in the mesolimbic pathway, particularly within the nucleus accumbens. However, the speaker's generalization that pain removal causes an increase across all catecholamines, including norepinephrine and epinephrine, requires qualification: acute pain and stress activate noradrenergic and adrenergic sympathetic pathways, which typically decrease back toward baseline upon cessation of the stressor rather than surge.

1:02:20Andrew Hubermanneeds contexthigh

Prescription stimulants such as Adderall and Vyvanse are amphetamines that primarily release catecholamines, mainly dopamine and epinephrine.

"What do all those stimulants do? They release the catecholamines, mainly dopamine and epinephrine. They they are amphetamines, okay?" (said at 1:02:20)

Adderall (mixed amphetamine salts) and Vyvanse (lisdexamfetamine, a prodrug of dextroamphetamine) are indeed amphetamine psychostimulants whose primary central mechanism of action is promoting the efflux and inhibiting the reuptake of catecholamines. However, the two primary catecholamines released and elevated in the central nervous system are dopamine and norepinephrine (noradrenaline), rather than epinephrine (adrenaline), which is primarily a peripheral hormone produced by the adrenal medulla.

3:42:46Andrew Hubermanneeds contextmoderate

Exposing the eyes to amber or red light before sleep prevents the elevation in cortisol caused by exposure to blue-wavelength artificial light.

"and just going to amber or red lights before sleep for about half an hour. It's known to prevent some cortisol increase that can come from bright lights of the blue variety." (said at 3:42:46)

Switching from blue-enriched or bright light to long-wavelength (amber or red) light in the evening avoids the stimulating, hypothalamic-pituitary-adrenal (HPA) axis–activating effects of short-wavelength light. Randomized laboratory studies and systematic reviews confirm that exposure to blue or bright white light stimulates salivary cortisol increases compared to red or dim light conditions, which do not elicit this cortisol surge. However, the claim requires context: light-induced cortisol surges are most robustly documented during morning/post-awakening and late-night hours, whereas the predominant endocrine disruption caused by pre-sleep blue light exposure (and prevented by amber/red light) is the suppression of melatonin, as baseline cortisol is normally at its diurnal nadir before bedtime.

2:40:39Andrew Hubermanneeds contextmoderate

The age at which someone has their first alcoholic drink is one of the strongest determinants of whether they will develop alcoholism.

"One of the strongest determinants of whether or not somebody becomes an alcoholic is the age at which they took their first drink. So very, very young, higher likelihood they'll become an alcoholic, and so on." (said at 2:40:39)

Large-scale epidemiological cohorts consistently show a robust association between an earlier age at first drink and a markedly higher risk of developing alcohol dependence (alcohol use disorder). However, calling it a 'determinant' warrants qualification: twin and family studies indicate that this association is largely non-causal, acting primarily as an early behavioral marker reflecting shared underlying genetic liabilities, personality traits (such as behavioral disinhibition and impulsivity), and familial environmental factors.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.